Synektik

Synektik OCF/Debt

The Operating Cash Flow to Debt Ratio of Synektik (SNT.WA) as of Oct 31, 2026 is 193.23 %. In the previous year, Operating Cash Flow to Debt Ratio was 365.90 % — a change of -47.19% (lower).

OCF/Debt

193.23 %

YoY

-47.19%

Last updated:

Operating Cash Flow to Debt Ratio of Synektik is 2025 193.23 % . Operating Cash Flow to Debt Ratio of Synektik was 2024 365.90 % . It decreases by -47.19% lower compared to the previous year.

The Synektik OCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF/Debt
Date
OCF/Debt
Jan 1, 2018
32.31 PLN
Jan 1, 2019
111.30 PLN
Jan 1, 2020
67.69 PLN
Jan 1, 2021
119.50 PLN
Jan 1, 2022
-16.77 PLN
Jan 1, 2023
504.74 PLN
Jan 1, 2024
365.90 PLN
Jan 1, 2025
193.23 PLN
The Synektik OCF/Debt history
YEAROCF/DebtYoY
193.23 %-47.19%
365.90 %-27.51%
504.74 %-3,110.41%
-16.77 %-114.03%
119.50 %+76.54%
67.69 %-39.19%
111.30 %+244.49%
32.31 %-92.74%
445.02 %-415.60%
-141.01 %-309.34%
67.36 %-30.52%
96.94 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synektik Stock analysis

What does Synektik do? Synektik SA generates revenue through its PACS software, which enables diagnostic imaging laboratories to operate efficiently. The company also sells medical equipment and provides services through its imaging equipment services center. Synektik SA partners with Siemens and holds a 100% stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o, which it acquired by raising its stake on November 28, 2013. The firm's research laboratory conducts acceptance and specialist tests on X-ray equipment, contributing to its service offerings. The primary buyers of Synektik SA's products include diagnostic imaging laboratories that require PACS software for their operations. Medical equipment is sold to healthcare facilities, while the research laboratory services are utilized by entities needing X-ray equipment testing. The company's partnership with Siemens supports its medical equipment sales and services. Synektik SA's revenue streams are derived from software licensing, medical equipment sales, and specialized testing services. The company's focus on diagnostic imaging solutions and its ownership of Miedzynarodowe Centra Medyczne Inwestycje Sp z o o position it within the medical technology sector, targeting healthcare providers and imaging laboratories. Synektik is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synektik stock

Operating Cash Flow to Debt Ratio of Synektik is 193.23 % in 2025.

Operating Cash Flow to Debt Ratio of Synektik changed from 365.90 % to 193.23 %, representing a -47.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio Synektik since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's Synektik with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Synektik

All Key Metrics — Synektik